title: [Effect of dopamine deficiency on the preparation of visually guided saccadic eye movements].
abstract: Parameters of saccadic eye movements were studied in patients with Parkinson's disease and control subjects. In parkinsonian patients, the number of slow regular saccades was shown to be increased, and the number of express saccades was shown to be decreased. As a result the mean of saccade latency in patients was longer than in the control group. Moreover, the percentage of multistep saccades in patients with Parkinson's disease. In this case, not one but two or three saccades were performed with smaller amplitude to the target. We point, that the multistep saccades occurred mainly among the express saccades. Obviously, the dopamine deficiency distinguishing parkinsonian patients takes the primary part in the development of saccadic disorders. Degeneration of the nigrostriatal dopamine pathway results in imbalance in activity of the direct and indirect output pathways of the striatum. We suppose that this leads to inhibition of neurons activity in the superior colliculus during the saccade performance, which results in the early saccade interruption. In support of this reasoning, the mean of saccade latency and the percentage of the multistep saccades decreased in patients with Parkinson's disease after dopamine D2/D3 agonist (piribedil) treatment, due to activity restoration of the indirect pathway.
authors.forename: P O
authors.initials: PO
authors.lastname: Ratmanov
authors.forename: D A
authors.initials: DA
authors.lastname: Napalkov
authors.forename: R R
authors.initials: RR
authors.lastname: Bogdanov
authors.forename: A V
authors.initials: AV
authors.lastname: Latanov
authors.forename: L G
authors.initials: LG
authors.lastname: Turbina
authors.forename: V V
authors.initials: VV
authors.lastname: Shul'govskiĭ
mesh_terms: D004298:Dopamine / Q000172:deficiency*; D018491:Dopamine Agonists / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology*; D010891:Piribedil / Q000008:administration & dosage*; D012438:Saccades / Q000187:drug effects*
chemical_list: D018491:Dopamine Agonists; D010891:Piribedil; D004298:Dopamine